Stock XENE XENON PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Xenon Pharmaceuticals Inc.

Equities

XENE

CA98420N1050

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-02 pm EDT 		5-day change 1st Jan Change
36.56 USD -3.00% Intraday chart for Xenon Pharmaceuticals Inc. -1.19% -20.63%
Jun. 12 Transcript : Xenon Pharmaceuticals Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 04:00 PM
Jun. 04 Transcript : Xenon Pharmaceuticals Inc. - Shareholder/Analyst Call

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Xenon Pharmaceuticals Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 04:00 PM
Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
GL
Transcript : Xenon Pharmaceuticals Inc. - Shareholder/Analyst Call
Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual Meeting
GL
Xenon Pharmaceuticals Inc. Presents Data from Phase 2 X-Nova Clinical Trial of Azetukalner in Major Depressive Disorder At the American Society of Clinical Psychopharmacology 2024 Annual Meeting
CI
Encephalopathy Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)
AQ
Transcript : Xenon Pharmaceuticals Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 03:40 PM
Wedbush Trims Xenon Pharmaceuticals' Price Target to $50 From $51, Maintains Outperform Rating
MT
Xenon Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Xenon Pharmaceuticals Q1 Net Loss Narrows
MT
Transcript : Xenon Pharmaceuticals Inc., Q1 2024 Earnings Call, May 09, 2024
Xenon Pharmaceuticals: Q1 Earnings Snapshot
AQ
Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
GL
Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
AQ
Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024
GL
Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference
GL
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update
GL
Xenon Pharmaceuticals Inc. Announces Board Resignations
CI
Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting
GL
Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. XENE Stock
  4. News Xenon Pharmaceuticals Inc.